PTCT Q1 2017 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PTCTPTC Therapeutics, Inc.

$5B

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$27M+40.5% YoY

Gross Profit

$27M99.9% margin

Operating Income

-$26M-99.3% margin

Net Income

-$29M-109.5% margin

EPS (Diluted)

$-0.85

QoQ Revenue Growth

+5.4%

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$249M

Total Liabilities

$148M

Stockholders' Equity

$101M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$19M	+40.5%
Gross Profit	$27M	-$13M	+312.0%
Operating Income	-$26M	-$38M	+31.4%
Net Income	-$29M	-$41M	+29.5%